Skip to main content

Table 1 Patient Demographics in Evaluable Population

From: Daptomycin Therapy for Osteomyelitis: A Retrospective Study

Characteristics Total (n = 71)
Gender  
  Female 36 (51)
  Male 35 (49)
Age group (years)  
  ≤ 50 20 (28)
  51-65 24 (33)
  ≥ 66 27 (38)
Weight, kg (median [min, max]) 82 [37, 136]
Type of osteomyelitis  
  Contiguous 45 (63)
  Hematogenous 12 (17)
  Unknown 14 (20)
Chronic presentation 29 (41)
Anatomic site  
  Foot/Toe 38 (54)
  Vertebrae 13 (18)
  Sacrum 5 (7)
  Sternum 4 (6)
  Tibia/Fibula 3 (4)
  Knee 2 (3)
  Skull 2 (3)
  Femur 1 (1)
  Finger 1 (1)
  Rib 1 (1)
  Other 1 (1)
Multiple osteomyelitis sites 6 (8)
Concomitant infections  
  Skin and skin structure infection† 9 (13)
  Bacteremia 5 (7)
  Deep surgical site infection 5 (7)
  Urinary tract infection/pyelonephritis 3 (4)
  Septic arthritis 1 (1)
Underlying diseases*  
  Hypertension 34 (48)
  Diabetes mellitus 31 (44)
  Other cardiovascular disease 10 (14)
  Peripheral vascular disease 13 (18)
  Anemia/All hematologic diseases 10 (14)
  Cardiac Arrhythmias 10 (14)
ICU stay during daptomycin 6 (9)
Initial CrCl < 30 ml/min 3 (4)
On dialysis 0 (0)
  1. Data expressed as n (%) unless otherwise indicated.
  2. † Types: major abscess n = 4, ulcer n = 2, wound n = 2, uncomplicated n = 1.
  3. * Patients may have more than one underlying disease.